Genetic manipulation of murine embryonic stem cells with enhanced green fluorescence protein and sulfatase-modifying factor i genes

Cytotherapy

Volumn 12, Issue 3, 2010, Pages 400-407

  Zhao, Guoying ^a   Karageorgos, Litsa ^a   Hutchinson, Rhonda G ^a   Hopwood, John J ^a,b   Hemsley, Kim ^a,b  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Embryonic stem cells; Enhanced green fluorescence protein; Gene expression; Mucopolysaccharidosis type IIIA; Sulfamidase; Sulfatase modifying factor I

Indexed keywords

ELONGATION FACTOR 1ALPHA; ENHANCED GREEN FLUORESCENT PROTEIN; ENZYME; N SULFOGLUCOSAMINE SULFOHYDROLASE; SULFATASE; SULFATASE MODIFYING FACTOR I; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CYTOMEGALOVIRUS; DOWN REGULATION; EMBRYONIC STEM CELL; ENZYME MODIFICATION; GENE EXPRESSION; GENETIC MANIPULATION; KARYOTYPING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TRANSGENE;

EID: 77950550603     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.3109/14653241003695026     Document Type: Article

References (38)

1. Hemsley KM, King B, Hopwood JJ. Injection of recombinant human sulfamidase into the CSF via the cerebellomedullary cistern in MPSIIIA mice. Mol Genet Metab. 2007;90: 313-328
2. Meng X-L, Shen JS, Ohashi T, Maeda H, Kim SU, Eto Y. Brain transplantation of genetically engineered human neural stem cells globally corrects brain lesions in the mucopolysaccharidosis type vii mouse. J Neurosci Res. 2003; 74:266-277
3. Snyder EY, Taylor RM, Wolfe JH. Neural progenitor cell engraftment corrects lysosomal storage throughout the MPS VII mouse brain. Nature. 1995;374:367-370
4. Givogri MI, Galbiati F, Fasano S, Amadio S, Perani L, Superchi D, et al. Oligodendroglial progenitor cell therapy limits central neurological defi cits in mice with metachromatic leukodystrophy. J Neurosci Res. 2006;26:3109-3119
5. Kawabata K, Migita M, Mochizuki H, Miyake K, Igarashi T, Fukunaga Y, et al. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres. Brain Res. 2006;1094:13-23.
6. Zhao G, McCarthy NF, Sheehy PA, Taylor RM. Comparison of the behavior of neural stem cells in the brain of normal and twitcher mice after neonatal transplantation. Stem Cells Devel. 2007;16:429-438
7. Sawada T, Tanaka A, Higaki K, Takamura A, Nanba E, Seto T, et al. Intracerebral cell transplantation therapy for murine GM1 gangliosidosis. Brain Devel. 2008. doi: 10.1016/ j.rbraindev.2008.11.004
8. Bhaumik M, Muller VJ, Rozaklis T, Johnson L, Dobrenis K, Bhattacharyya R, et al. A mouse model for mucopolysaccharidosis type IIIA (Sanfi lippo syndrome). Glycobiol. 1999;9:1389-1396
9. Crawley AC, Gliddon BL, Auclair D, Brodie SL, Hirte C, King BM, et al. Characterization of a C57BL/6 congenic mouse strain of mucopolysaccharidosis type IIIA. Brain Res. 2006;1104:1-17.
10. Lau AA, Hemsley KM, Meedeniya A, Hopwood JJ. In vitro characterization of genetically modifi ed embryonic stem cells as a therapy for murine mucopolysaccharidosis type IIIA. Mol Genet Metab. 2004;81:86-95.
11. Robinson AR, Zhao G, Rathjen J, Rathjen PD, Hutchinson RG, Eyre HJ, et al. Embryonic stem cell-derived glial precursors as a vehicle for sulfamidase production in the MPS-IIIA mouse brain. In press.
12. Cosma MP, Pepe S, Annunziata I, Newbold RF, Grompe M, Parenti G, et al. The multiple sulfatase defi ciency gene encodes an essential and limiting factor for the activity of sulfatases. Cell. 2003;113:445-456
13. Dierks T, Schmidt B, Borissenko LV, Peng J, Preusser A, Mariappan M, et al. Multiple sulfatase defi ciency is caused by mutations in the gene encoding the human C (alpha)-formylglycine generating enzyme. Cell. 2003;113: 435-444
14. Fraldi A, Biffi A, Lombardi A, Visigalli I, Pepe S, Settembre C, et al. SUMF1 enhances sulfatase activities in vivo in fi ve sulfatase defi ciencies. Biochem J. 2007;403: 305-312
15. Almeciga-Diaz CJ, Rueda-Paramo MA, Espejo AJ, Echeverri OY, Montano A, Tomatsu S, et al. Effect of elongation factor 1a promoter and SUMF1 over in vitro expression of N-acetylgalactosamine-6-sulfate sulfatase. Mol Biol Rep. 2008; 36:1863-1870.
16. Fraldi A, Hemsley K, Crawley A, Lombardi A, Lau A, Sutherland L, et al. Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes. Human Mol Gen. 2007;16:2693-2702
17. Hemsley KM, Beard H, King B, Hopwood JJ. Effect of high dose, repeated intra-CSF injection of sulphamidase on neuropathology in MPS IIIA mice. Genes Brain Behav. 2008; 7:740-753
18. Li Y, Horwitz MS. Use of green fl uorescent protein in s tudies of apoptosis of transfected cells. Biotechniques. 1997;23: 1026-1029
19. Yoon Y, Pitts K, McNiven M. Studying cytoskeletal dynamics in living cells using green fl uorescent protein. Mol Biotechnol. 2002;21:241-250
20. Chan KK-K, Wu SM, Nissom PM, Oh SKW, Choo ABH. Generation of high-level stable transgene expressing human embryonic stem cell lines using Chinese hamster elongation factor-1 alpha promoter system. Stem Cells Devel. 2008; 17:825-836
21. Wang R, Liang J, Jiang H, Qin L-J, Yang H-T. Promoterdependent EGFP expression during embryonic stem cell propagation and differentiation. Stem Cells Devel. 2008; 17:279-289
22. Hopwood JJ, Elliott H. The diagnosis of the Sanfi lippo C syndrome, using monosaccharide and oligosaccharide substrates to assay acetyl-CoA: 2-amino-2-deoxy-alpha-glucoside N-acetyltransferase activity. Clin Chim Acta. 1982; 112: 67-75.
23. Freshney RI. Characterization. In: Freshney RI. Culture of Animal Cells: a Manual of Basic Technique. 4th ed. Hoboken: Wiley-Liss; 2000. p. 229-257.
24. Liu JW, Pernod G, Dunoyer-Geindre S, Fish RJ, Yang H, Bounameaux H, et al. Promoter dependence of transgene expression by lentivirus-transduced human blood-derived endothelial progenitor cells. Stem Cells. 2006;24:199-208.
25. Makrides SC. Components of vectors for gene transfer and expression in mammalian cells. Protein Exp Purif. 1999; 17:183-202.
26. Chung S, Andersson T, Sonntag K-C, Bjorklund L, Isacson O, Kim K-S. Analysis of different promoter systems for effi - cient transgene expression in mouse embryonic stem cell lines. Stem Cells. 2002;20:139-145
27. Ward CM, Stern PL. The human cytomegalovirus immediate- early promoter is transcriptionally active in undifferentiated mouse embryonic stem cells. Stem Cells. 2002; 20: 472-475
28. Zeng X, Chen J, Sanchez JF, Coggiano M, Dillon-Carter O, Petersen J, et al. Stable expression of hrGFP by mouse embryonic stem cells: promoter activity in the undifferentiated state and during dopaminergic neural differentiation. Stem Cells. 2003;21:647-653
29. Robinson AJ, Crawley AC, Hopwood JJ. Over-expression of human lysosomal alpha-mannosidase in mouse embryonic stem cells. Mol Gen Metab. 2005;85:203-212
30. de Felipe P. Polycistronic viral vectors. Curr Gene Ther. 2002;2:355-378
31. Kim J-H, Do H-J, Choi S-J, Cho H-J, Park K-H, Yang H-M, et al. Effi cient gene delivery in differentiated human embryonic stem cells. Exp Mol Med. 2005; 37:36 - 44
32. Erratum appears in Exp Mol Med. 2006; 38:589.
33. Liu HS, Jan MS, Chou CK, Chen PH, Ke NJ. Is green fl uorescent protein toxic to the living cells? Biochem Biophys Res Comm. 1999;260:712-717
34. Costa M, Dottori M, Ng E, Hawes SM, Sourris K, Jamshidi P, et al. The HESC line Envy expresses high levels of GFP in all differentiated progeny. Nature Meth. 2005;2:259-260
35. Liew C-G, Draper JS, Walsh J, Moore H, Andrews PW. Transient and stable transgene expression in human embryonic stem cells. Stem Cells. 2007;25:1521-1528 (Pubitemid 47106021)
36. Swenson ES, Price JG, Brazelton T, Krause DS. Limitations of green fl uorescent protein as a cell lineage marker. Stem Cells. 2007;25:2593-2600
37. Taghizadeh RR, Sherley JL. CFP and YFP, but not GFP, provide stable fl uorescent marking of rat hepatic adult stem cells. J Biomed Biotechnol. 2008;2008:453-590.
38. Laker C, Meyer J, Schopen A, Friel J, Heberlein C, Ostertag W, et al. Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation. J Virol. 1998;72:339-348